Efficacy of cetuximab in the treatment of squamous cell carcinoma
S Preneau, E Rio, A Brocard, L Peuvrel… - … treatment, 2014 - Taylor & Francis
… treatment of SCCHN and colorectal carcinoma. Based on the results obtained in head and
neck cancer (Citation4), cetuximab has been recently proposed in the treatment … of cetuximab …
neck cancer (Citation4), cetuximab has been recently proposed in the treatment … of cetuximab …
[HTML][HTML] The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck
R Mehra, RB Cohen, BA Burtness - Clinical advances in …, 2008 - ncbi.nlm.nih.gov
… role of cetuximab in the treatment of HNSCC. … cetuximab earlier in the course of treatment
of HNSCC, especially with concurrent chemo-RT and in the induction setting, would cetuximab …
of HNSCC, especially with concurrent chemo-RT and in the induction setting, would cetuximab …
Treatment of recurrent squamous cell carcinoma of the skin with cetuximab
JE Bauman, KD Eaton, RG Martins - Archives of Dermatology, 2007 - jamanetwork.com
… cells, including lymph node metastases. This drug, approved for treatment of squamous cell
carcinoma of … of SCCS who have been treated with palliative cetuximab. The drug was well …
carcinoma of … of SCCS who have been treated with palliative cetuximab. The drug was well …
[HTML][HTML] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner, PM Harari, J Giralt, N Azarnia… - … England Journal of …, 2006 - Mass Medical Soc
… For these reasons, we conducted a randomized, phase 3 study to determine the effect of
adding cetuximab to radiotherapy in the treatment of patients with locoregionally advanced …
adding cetuximab to radiotherapy in the treatment of patients with locoregionally advanced …
The role of cetuximab in the treatment of squamous cell cancer of the head and neck
B Burtness - Expert opinion on biological therapy, 2005 - Taylor & Francis
… cell carcinoma of the head and neck, as is cetuximab monotherapy. When cetuximab is …
to cisplatin monotherapy in the first-line treatment of recurrent or metastatic squamous cell …
to cisplatin monotherapy in the first-line treatment of recurrent or metastatic squamous cell …
Cetuximab in the treatment of squamous cell carcinoma of the head and neck
P Specenier, JB Vermorken - Expert review of anticancer therapy, 2011 - Taylor & Francis
… cell carcinomas, which commonly overexpress the EGF receptor (EGFR). Cetuximab is a …
, and in addition induces antibody-dependent cellular cytoxicity. In a randomized Phase III …
, and in addition induces antibody-dependent cellular cytoxicity. In a randomized Phase III …
Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer
SKA Blick, LJ Scott - Drugs, 2007 - Springer
… cetuximab. In a large (n = 572) randomised trial in heavily pretreated patients with mCRC,
the addition of cetuximab treatment … plus cetuximab for squamous-cell carcinoma of the head …
the addition of cetuximab treatment … plus cetuximab for squamous-cell carcinoma of the head …
Effect of cetuximab treatment in squamous cell carcinomas
M Nestor - Tumor Biology, 2010 - Springer
… monoclonal antibody cetuximab in a panel of cultured squamous cell carcinoma cell lines. …
), is emerging as a promising agent for treatment of several cancers. As this antibody comes …
), is emerging as a promising agent for treatment of several cancers. As this antibody comes …
Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin
E Maubec, P Petrow, I Scheer-Senyarich… - Journal of Clinical …, 2011 - ascopubs.org
… to treat in the case of early disease progression. We also studied efficacy as a function of
skin toxicity as documented in SCCHN after cetuximab treatment. Since cetuximab sensitivity is …
skin toxicity as documented in SCCHN after cetuximab treatment. Since cetuximab sensitivity is …
Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
AD Santin, MW Sill, DS McMeekin, MM Leitao Jr… - Gynecologic …, 2011 - Elsevier
… Twenty-four patients (68.6%) had a squamous cell carcinoma. Grade 3 adverse events
possibly related to cetuximab included dermatologic (n = 5), GI (n = 4), anemia (n = 2), …
possibly related to cetuximab included dermatologic (n = 5), GI (n = 4), anemia (n = 2), …
相关搜索
- cetuximab in the treatment cell cancer
- component of multimodality treatment cell carcinoma
- squamous cell carcinoma
- study of cetuximab cell carcinoma
- cutaneous squamous cell carcinoma cetuximab radiotherapy
- neck squamous cell carcinoma cetuximab therapy
- treatment of unresectable cell carcinoma
- trial of cetuximab cell carcinoma
- cetuximab in a patient cell carcinoma
- head and neck cell carcinoma
- efficacy of cetuximab cell carcinoma
- review of its use cell carcinoma
- role of cetuximab cell carcinoma
- cetuximab in the treatment neck cancer
- cutaneous squamous cell carcinoma concurrent cetuximab